Stock SNGX SOLIGENIX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Soligenix, Inc.

Equities

SNGX

US8342235053

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-24 pm EDT 		5-day change 1st Jan Change
0.365 USD +1.67% Intraday chart for Soligenix, Inc. -7.03% -51.80%
May. 23 Sector Update: Health Care Stocks Retreat Late Afternoon MT
May. 23 Sector Update: Health Care Stocks Lower Thursday Afternoon MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting
PR
Sector Update: Health Care Stocks Retreat Late Afternoon
MT
Sector Update: Health Care Stocks Lower Thursday Afternoon
MT
Soligenix Seeks Shareholders' Approval for Reverse Stock Split; Shares Fall
MT
Soligenix Encourages Stockholders to Vote "FOR" Reverse Stock Split
PR
PRISM MarketView Highlights Soligenix, Inc. as it Builds on Compelling Phase 3 Data with Key Catalysts on the Horizon
AQ
Soligenix Encourages Stockholders to Vote Prior to Annual Meeting
PR
Soligenix, Inc. Announces Positive Clinical Results from HyBryte Compatibility Study in the Treatment of Cutaneous T-Cell Lymphoma
CI
Soligenix Announces Recent Accomplishments and First Quarter 2024 Financial Results
AQ
Soligenix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Soligenix Announces Recent Accomplishments And First Quarter 2024 Financial Results
PR
Soligenix to Present at Upcoming Conferences
PR
Soligenix Extends Patent Protection for Its Filovirus Vaccine Platform to the United Kingdom and South Africa
CI
Soligenix Announces Pricing of $4.75 Million Public Offering
PR
Sector Update: Health Care Stocks Softer Late Afternoon
MT
Sector Update: Health Care Stocks Gain Monday Afternoon
MT
Soligenix Shares Rise After Active Ingredient in MarVax Gets US FDA's Orphan Drug Designation
MT
Soligenix Shares Rise After SuVax Gets Orphan Drug Designation from US FDA
DJ
FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Marburg Marburgvirus Infection
PR
FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Sudan Ebolavirus Infection
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SNGX Stock
  4. News Soligenix, Inc.